title: Maternal DRB1*1501, DQA1*0102, DQB1*0602 haplotype in fetomaternal alloimmunization against human platelet alloantigen HPA-6b (GPIIIa-Gln489).
abstract: Fetomaternal incompatibility of platelet alloantigens may lead to alloimmunization and neonatal alloimmune thrombocytopenia (NAIT). Human platelet alloantigen (HPA) 6b, which associates with residue Gln 489 of platelet membrane glycoprotein IIIa, has been described as a cause of NAIT. We have studied the MHC genes of all available family members in the six thus far reported families with a thrombocytopenic newborn and fetomaternal HPA-6b incompatibility. Maternal HPA-6b antibodies could be detected in five mothers to the altogether seven thrombocytopenic male infants. The MHC genes HLA-DRB, -DQA1, -DQB1, -DPB1, TAP1,2 and HSP70-Hom were studied by using polymerase chain reaction (PCR)-based DNA analysis methods. All five mothers with detectable circulating HPA-6b antibodies at the time of delivery shared an identical DRB1*1501, DQA1*0102, DQB1*0602 haplotype. The sixth, HPA antibody negative mother and a HPA-6b-negative mother to a healthy HPA-6b+ child were negative for this haplotype. The frequency of DRB1*15-positive haplotype was increased in immunized mothers (100%) as compared with the general Finnish population (27%), but the association was not statistically significant after correction. We conclude that there is a potential association between the MHC haplotype DRB1*1501, DQA1*0102, DQB1*0602 and alloimmunization to the HPA-6b antigen and that this alloimmunization probably involves different HLA class II molecules from immunization to HPA-1a.
authors.affiliation: Finnish Red Cross Blood Transfusion Service, Helsinki, Finland. pia.westman@bts.redcross.fi
authors.forename: P
authors.initials: P
authors.lastname: Westman
authors.forename: S
authors.initials: S
authors.lastname: Hashemi-Tavoularis
authors.forename: V
authors.initials: V
authors.lastname: Blanchette
authors.forename: S
authors.initials: S
authors.lastname: Kekomäki
authors.forename: M
authors.initials: M
authors.lastname: Laes
authors.forename: L
authors.initials: L
authors.lastname: Porcelijn
authors.forename: R
authors.initials: R
authors.lastname: Kekomäki
mesh_terms: D016824:Antigens, Human Platelet / Q000276:immunology*; D001792:Blood Platelets / Q000276:immunology; D004247:DNA / Q000032:analysis; D005260:Female; D005802:Genes, MHC Class II / Q000235:genetics; D006683:HLA-DQ Antigens / Q000235:genetics*; D059848:HLA-DQ alpha-Chains; D059866:HLA-DQ beta-Chains; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006239:Haplotypes; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007231:Infant, Newborn; D007519:Isoantigens / Q000276:immunology; D008297:Male; D008431:Maternal-Fetal Exchange / Q000276:immunology; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D013921:Thrombocytopenia / Q000151:congenital* / Q000276:immunology
chemical_list: C108543:6b alloantigen, human; D016824:Antigens, Human Platelet; D006683:HLA-DQ Antigens; D059848:HLA-DQ alpha-Chains; D059866:HLA-DQ beta-Chains; C069050:HLA-DQA1 antigen; C069051:HLA-DQB1 antigen; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D007519:Isoantigens; D004247:DNA